| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |